
Search News
-
Published on Apr 28, 2025
'The invisible disease' | Raising awareness of Lupus | 13News at Noon on April 28, 2025
Local organizations are working to raise awareness of a disease the impacts countless Hoosiers but is often called "invisible." Author: wthr.com Published: 5:05 PM EDT April 28, 2025 Updated: 5:05 PM EDT April 28, 2025
Source: WTHR - Indiana - Pending -
Published on Apr 26, 2025
Rugby: Brave Lupus score 9 tries to overpower bottom club D-Rocks
Michael Leitch of Brave Lupus Tokyo scores a try during a Japan Rugby League One match against the Urayasu D-Rocks at Prince Chichibu Memorial Rugby Ground in Tokyo on April 25, 2025. (Kyodo) TOKYO (Kyodo) -- Brave Lupus Tokyo beat the struggling Urayasu D …
Source: The Mainichi - Neutral -
Published on Apr 26, 2025
Ophthalmic Posterior Segment OCTA Metrics as Potential Biomarkers for Systemic Involvement in Systemic Sclerosis, ...
Introduction Optical coherence tomography angiography (OCTA) is an imaging modality that allows for non-invasive, quantitative imaging of the microvasculature, including of the eye and skin, in three dimensions. OCTA is widely used in ophthalmology in …
Source: Dove Medical Press - Neutral -
Published on Apr 24, 2025
Caribou lays off 32% of staff, cuts lupus program
Source: Endpoints News - Neutral -
Published on Apr 24, 2025
Vertebral Osteoporosis in Systemic Lupus Erythematosus: A Possible Involvement of Inflammation-Related Osteoblast ...
Zhaobai Lao,1,* Xiaogang Chen,2,* Xin Chen,1,* Helou Zhang,1 Zhiguo Zhang,1 Yishan Bian,1 Chengcong Zhou,1 Kun Tian,2 Hongting Jin,1 Fangda Fu,1 Chengliang Wu,1 Kaifeng Gan,3 Hongfeng Ruan1 1Institute of Orthopaedics and …
Source: Dove Medical Press - Neutral -
Published on 06:43 GMT
'Doctors said my symptoms were anxiety, then I had to have my leg removed'
When Erin Lazarus started suffering from strange symptoms, doctors told her it was just anxiety. She was 23, completing her postgraduate degree and about to start her dream job as a foreign exchange dealer at Investec. But despite the doctors’ reassurance …
Source: Bristol Post - Neutral -
Published on 10:32 GMT
Cullinan Therapeutics to begin US trial of CLN-978 to treat Sjögren’s disease
US-based biopharmaceutical company Cullinan Therapeutics is due to begin a domestic trial of its drug candidate CLN-978 for treating Sjögren’s disease (SjD). The trial will recruit individuals in the US with active, moderate-to-severe SjD who meet the 2016 …
Source: Clinical Trials Arena - Pending -
Published on 02:40 GMT
Asembia AXS25: Cell and Gene Therapies Enter New Phase of Growth in Specialty Pharmacy
Cell and gene therapies (CGTs) are quickly moving to the forefront of specialty pharmacy and have become central to the future of pharmaceutical innovation, according to a panel discussion held during a business session titled “Cell, Gene and Beyond: What’ …
Source: Pharmacy Times - Neutral -
Published on 11:34 GMT
FDA approves AbbVie’s upadacitinib for giant cell arteritis
The US Food and Drug Administration (FDA) has granted approval for AbbVie’s 15mg Rinvoq (upadacitinib) to treat adults with giant cell arteritis (GCA). The approval follows the recent marketing authorisation granted by the European Commission for the same …
Source: Pharmaceutical Technology - Pending